Shortages of several generic chemotherapy drugs are straining hospital supply chains and raising concerns that cancer centers may need to ration treatment for some patients, according to a June 24 New York Times report. Manufacturing problems, shipping delays and decisions…

Four major hospital associations are calling on federal regulators to intervene after Eli Lilly followed through on its threat to cut off 340B drug pricing to hospitals that refused to comply with its in-house pharmacy claims reporting requirements. Eli Lilly…

The FDA has changed its position on two separate therapies in recent weeks, allowing a melanoma treatment and a Huntington’s disease gene therapy to advance toward approval after earlier rejections. Replimune reached an agreement with the FDA on a path…

Demand for pharmacists surged in the final months of 2025, with year-end data showing the strongest quarterly growth in the reporting period, according to the Pharmacy Workforce Center’s fourth-quarter 2025 Pharmacy Demand Report. Here are six things to know:

The American Society of Health‑System Pharmacists has appointed Mandy Leonard, PharmD, vice president of its Office of Accreditation Services, effective July 30. In her new role, she will oversee strategic and operational initiatives related to the accreditation of pharmacy residency…

Most health system pharmacy executives are looking to stay in their organizations, and a growing share want to run more of the enterprise, according to a national survey.  In a survey of 788 hospital and health system pharmacy leaders published…

As workforce shortages continue to pressure pharmacy departments, some health systems are investing in a longer-term solution: building their own talent pipelines. Rather than relying solely on external hiring, organizations are creating technician training programs, expanding residency positions and developing…

Inventia Healthcare Limited is recalling 11,460 bottles of Chlorthalidone Tablets USP, 25 mg, a blood pressure medication distributed nationwide after the product failed dissolution specifications. The recall was initiated June 5 and was classified as a Class II recall by…

Boston (Mass.) Children’s Hospital has launched a neurologic drug research program through a new research agreement focused on developing therapies for patients with unmet medical needs. The agreement builds on a strategic collaboration announced in July 2025 with NS Pharma,…

Major drugmakers are advancing therapies that could affect hospital formularies, oncology programs, infectious disease management and obesity care. Here are six recent pharma developments healthcare leaders should know.  Here are six recent moves to know: